Clinical Production Architecture

Production Decomposition

PDA does not measure "production" as a single aggregate number. Clinical production is decomposed into three primary procedure categories — restorative (fillings, crowns, bridges, implants), hygiene (prophy, scaling/root planing, periodontal surgery), and exams (comprehensive, periodic, limited) — plus a critical fourth category: non-billable time and procedures. Each category has independent benchmarks, margin profiles, and quality of earnings implications.

Aggregate production numbers mask the distribution problems that institutional buyers will isolate during due diligence. A practice showing $2M in annual production appears uniform until that production is decomposed by department and procedure category. The decomposition might reveal: general dentistry producing $1.4M (70% of total), specialty producing $400K (20%), and hygiene producing $200K (10%). That specialty department is underproducing relative to regional benchmarks. Or the restorative category might represent 65% of production when regional benchmarks show 48%, signaling a procedure mix variance that raises coding risk flags.

The forensic decomposition is: total production / procedure category / department / provider / collection rate by category. This reveals where the practice is outperforming or underperforming the market, and identifies which segments create institutional risk.

Treatment Presentation Benchmark

The optimized benchmark is $1,000 average case dollars presented per completed exam.

Percentile Distribution:

Percentile	Avg $/Exam Presented
Top 10%	$1,645
Top 25%	$1,004
Top 50% (Median)	$777
Top 75%	$625
Top 90%	$372

Annual revenue opportunity: $179,234 — the second-largest single operational opportunity after case acceptance. Calculated from ($1,000 optimized − $777 median) × 365 exams per provider annually × 5 providers.

This metric isolates patient education and treatment acceptance efficiency independent of marketing, new patient volume, or clinical outcomes. It measures how effectively the practice presents treatment options and educates patients on clinical needs. A practice presenting only $625 per exam is either (a) performing minimal diagnostic work, (b) identifying treatment needs but not presenting them effectively, or (c) experiencing patient financial barriers that prevent treatment discussion.

Three mechanisms improve case presentation rate:

Personalization: Practices that invest time understanding patient goals, financial comfort, and clinical priorities present significantly more treatment. A personalization conversation ("What are your biggest concerns about your dental health? What would winning look like for you?") conducted during the hygiene exam identifies which treatment categories the patient cares about most. This enables targeted presentation of high-value treatment aligned with patient priorities, rather than a generic "you need a crown, a filling, and scaling" approach. Practices with documented personalization protocols present $200-300 more per exam on average.

Internal specialty expansion: Referral of patient treatment to external specialists (endodontists, periodontists, oral surgeons) reduces in-house production and increases cost-per-patient. Practices expanding internal capability (e.g., doctor performing implant placement, therapist performing scaling/root planing, doctor performing basic endodontics or extractions) retain treatment dollars that would otherwise flow to specialists. This also improves patient experience — one location, one clinical narrative — which often improves case acceptance.

Financial delegation: Practices where the financial coordinator (not the doctor) explores flexible payment solutions, financing options, and treatment sequencing see materially higher case acceptance. This removes the clinical authority bias ("the doctor said I need it, so I probably do but I can't afford it") and replaces it with creative solution architecture ("Let's do root canal and core this month, then crown next quarter so we can fit your budget"). Practices that formalize financial conversations with scripted discovery ("What's your comfort level with monthly payment plans? Would you prefer to address this over multiple appointments?") and trained delegation see 15-25% higher case acceptance.

Billable vs. Non-Billable Analysis

The critical distinction between billable and non-billable production determines what survives institutional scrutiny.

Billable procedures are those that dental insurance will reimburse at the contracted rate or that patients agree to pay for independently. Standard diagnostic codes, restorative codes, surgical codes, and accepted periodontal codes are billable. A filling, a crown, an exam, a scaling/root planing — these generate claims and EOBs.

Non-billable production includes time spent on patient education, soft-tissue procedures without independent codes, treatment planning consultations, diagnostic imaging review, and any procedure billed under a group code that insurance may deny or delay. Additionally, production exceeding insurance benchmarks may not survive QoE scrutiny. If a practice shows 15% higher production per exam than regional insurance benchmarks, institutional buyers will assume upcoding or bundling patterns that create compliance exposure.

The quality of earnings risk emerges when production doesn't align with insurance claim records. A practice showing $1.5M in daily production but collecting only $1.1M has $400K in production variance. Some of this is legitimate (patient deductibles, out-of-network reimbursement delays). But if the variance exceeds regional norms by more than 5%, it signals coding patterns that create audit exposure.

Insurance benchmark alignment: PDA audits procedures against regional insurance benchmarks by code. If a practice's procedure distribution is materially different from the regional average, it's a flag. For example, if the regional benchmark for scaling/root planing is 2.1 per patient annually, and a practice shows 3.8 per patient, the variance suggests either legitimate increased periodontitis prevalence (rare) or coding pattern variance (more common). Buyers will dig into the clinical charts to validate the coding.

Exam Type Distribution

Production is also analyzed by exam type: comprehensive exams (new patients, typically 60-90 minutes), periodic exams (established patients, typically 30-45 minutes), and limited exams (specific problem-focused exams, typically 20-30 minutes).

Comprehensive-to-periodic ratio reveals case flow patterns and practice stability. A practice with a high periodic-to-comprehensive ratio (e.g., 8 periodic exams per comprehensive exam) has a stable but potentially stagnant patient base. New patient acquisition is steady, but patient churn is low. A practice with a low periodic-to-comprehensive ratio (e.g., 3 periodic per comprehensive) is acquiring new patients but losing existing patients to attrition — or the practice is very young and still building a stable base.

Limited exam ratio indicates whether the practice is managing emergencies or conducting planned care. A practice with 40% of exams classified as limited exams is probably handling emergency walk-ins and pain-driven visits. Practices optimizing case flow typically show 15-25% limited exams and 75-85% comprehensive + periodic combined.

Comprehensive exam production is higher than periodic and limited exams because more diagnostic time produces more treatment opportunity. If comprehensive exams are underutilized (e.g., new patients scheduled for periodic exams instead of comprehensive), the practice is missing diagnostic opportunity and suppressing case presentation. This appears as lower case acceptance not because of clinical skill, but because diagnostic work wasn't performed thoroughly.

Department-Level Production Analysis

Multi-specialty or multi-location practices must analyze production at the department level with independent collection rates. Aggregate collection rates mask individual department problems.

Department-level collection rate analysis: A practice showing 85% aggregate collection rate might have general dentistry at 88%, specialty at 73%, and hygiene at 92%. The 15-point spread between specialty (73%) and hygiene (92%) reveals a specialty-specific problem. Possible causes: specialty procedures (implants, complex restorative) have higher patient co-pays that create collection friction; insurance contracts for specialty procedures have different reimbursement terms; billing/coding for specialty procedures is less organized; or patient case acceptance is lower for high-cost specialty treatment.

Department-level production per provider: A five-provider practice might show general providers at $1.2M annually, the specialist at $900K, and visiting specialists at $600K. The specialist underproduction might indicate: patient referral patterns aren't delivering sufficient specialty case volume, the specialist is not fully utilized, or the specialist has different productivity expectations than general providers. This is diagnostic — it either reveals patient flow architecture problems or indicates that the specialist hire was inefficiently scaled.

Procedure-specific production patterns: Some departments generate high production but low collection (specialty surgical might produce $600K but collect $450K). Other departments generate lower production but high collection (hygiene might produce $400K and collect $395K). This reveals margin and cash flow dynamics — surgical departments are profit centers but create cash flow timing issues (insurance delays), while hygiene is high-margin and fast-collecting.

The Phantom Production Problem

Phantom production is the single most common QoE surprise. A practice recording $1.8M in daily production but collecting only $1.2M has $600K in variance — 33% of recorded production. Some variance is legitimate (patient deductibles, insurance denials on legitimate claims, OON write-offs). But >15% variance is a flag.

Root causes of phantom production:

Upcoding: Billing for more complex procedures than clinically performed. Example: billing a composite filling as an inlay, or billing simple scaling as scaling/root planing. This appears as production on the daily sheet but gets denied by insurance during claims processing, appearing as variance.

Bundling problems: Grouping multiple procedures under a single code or billing procedures that should be billed separately. Example: billing a prophylaxis and fluoride treatment as a single prophy (losing the fluoride fee). This reduces production recorded vs. fee schedule.

Code selection errors: Using outdated procedure codes, or codes outside the insurance contract's scope. This creates denials that manifest as variance.

Sequencing failures: Billing for procedures that require prerequisites. Example: billing for a crown without a crown code sequence in the patient's claim history. Insurance requires a root canal → build-up → crown sequence. Billing out of sequence generates denials.

Compliance exposure: Procedure mix or coding patterns that exceed insurance benchmarks by more than 5 standard deviations. This triggers insurance audits, which may result in claim recoupment requests or provider contract modifications. This appears as phantom production because the practice recorded revenue that it must refund.

Institutional buyers isolate phantom production by comparing daily production records against EOB records. If the practice shows $1.8M in daily production and received $1.2M in payments + patient payments, there's $600K variance to explain. The buyer will request:

1. Claims register showing claim submission dates and amounts
2. EOB history showing insurance reimbursements by claim date
3. Patient account aging showing uncollected patient balances (deductibles, co-pays)
4. Insurance appeals or recoupment records

If the variance cannot be attributed to known claim denials, patient balances, or appeals, the buyer assumes coding compliance risk and deducts the phantom production from pro-forma EBITDA. A $600K variance represents approximately $360K-$600K in valuation reduction at a 6x multiple.

The Collection Rate as Clinical Signal

Collection rate by procedure category is also a clinical efficiency signal. High collection on restorative but low collection on periodontal indicates either: periodontal procedures are being billed above insurance benchmarks (compliance risk), or patients are declining periodontal treatment due to cost (case acceptance problem).

Practices optimizing clinical outcomes often show lower production but higher collection because they're billing appropriately and collecting effectively. Practices showing high production but low collection have phantom production embedded in their reporting and create valuation risk.